The ligands of σ2-R (commonly its antagonists) are claimed to be neuroprotective in Alzheimer’s disease, while its agonists are reported to be cytotoxic in cancer. The gene discussed is TMEM97; the disease is early-onset autosomal dominant Alzheimer disease.